Phospholipidation of TLR7/8-active imidazoquinolines using a tandem phosphoramidite method-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Phospholipidation of TLR7/8-active imidazoquinolines using a tandem phosphoramidite method

Published:2016-05 Issue:19 Volume:57 Page:2063-2066
ISSN:0040-4039
Container-title:Tetrahedron Letters
language:en
Short-container-title:Tetrahedron Letters

Author:

Bazin Hélène G.,Bess Laura S.,Livesay Mark T.,Mwakwari Sandra C.,Johnson David A.

Funder

National Institute of Allergy and Infectious Diseases

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Biochemistry

Reference23 articles.

1. The Toll-like receptor 7 (TLR7)-specific stimulus loxoribine uncovers a strong relationship within the TLR7, 8 and 9 subfamily

2. Small anti-viral compounds activate immune cells via the TLR7 MyD88–dependent signaling pathway

3. Activation of anti-hepatitis C virus responses via Toll-like receptor 7

4. Synthesis and Structure−Activity-Relationships of 1H-Imidazo[4,5-c]quinolines That Induce Interferon Production

5. The antiviral activity of toll-like receptor 7 and 7/8 agonists

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Co-Delivery of Novel Synthetic TLR4 and TLR7/8 Ligands Adsorbed to Aluminum Salts Promotes Th1-Mediated Immunity against Poorly Immunogenic SARS-CoV-2 RBD;Vaccines;2023-12-23

2. A lipidated TLR7/8 adjuvant enhances the efficacy of a vaccine against fentanyl in mice;npj Vaccines;2023-07-10

3. Development of a TLR7/8 agonist adjuvant formulation to overcome early life hyporesponsiveness to DTaP vaccination;Scientific Reports;2022-10-18

4. Using Dual Toll-like Receptor Agonism to Drive Th1-Biased Response in a Squalene- and α-Tocopherol-Containing Emulsion for a More Effective SARS-CoV-2 Vaccine;Pharmaceutics;2022-07-12

5. New Phosphorylating Agents for the Synthesis of Phosphatidylethanolamines;Synthesis;2021-05-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3